Related Experiment Video
Updated: Jun 16, 2026

23:33
The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
Published on: February 28, 2012
83.9K
Evaluating the New Watchman FLX Pro 40 mm Device: A Case Study Series.
Philippe Taieb1, Marco Frazzetto1, Pedro Soares Teixeira1
1Harrington Heart & Vascular Institute, University Hospitals Cleveland Medical Center, Cleveland, Ohio, USA.
Summary
The 40mm WATCHMAN FLX Pro device shows 100% procedural success for left atrial appendage closure (LAAC) in patients with large left atrial appendages. Early results indicate a favorable safety profile, expanding treatment options for atrial fibrillation stroke prevention.
Area of Science:
- Cardiovascular Interventions
- Medical Device Technology
- Electrophysiology
Background:
- Left atrial appendage closure (LAAC) is a key stroke prevention strategy for atrial fibrillation (AF) patients unsuitable for anticoagulation.
- The novel 40mm WATCHMAN FLX Pro device offers enhanced thromboresistance and accommodates larger left atrial appendages (LAA).
- Limited clinical data exists for this specific larger device iteration.

